In this guest editorial, KVC’s executive director Nancy Goodman analyzes President Trump’s promise of $500 million in additional pediatric cancer funding over the next 10 years and calls for getting the NCI the increase in funding it deserves. more→
OUR OP-EDS, TALKS, SPEECHES
Mapping Cancer Disparities panel at the Atlantic’s People v. Cancer forum
Watch Kids v Cancer’s Executive Director Nancy Goodman speak about the need to lower kids’ age of eligibility for clinical trials. more→
2018 AACR Meeting Presentation by Nancy Goodman
On April 17th, Nancy Goodman made a presentation on the RACE for Children ACT at the 2018 annual meeting of the American more→
This week in pediatric oncology – Interview with Nancy Goodman (audio)
Dr. Timothy Cripe from Nationwide Children’s Hospital talks with Nancy Goodman, Founder and Executive Director of Kids v. Cancer, about accomplishments and her hopes for the future. more→
Eyes on immunotherapy: Nancy Goodman speaks at the Atlantic Forum Children & Cancer
A video on how Kids v Cancer is creating incentives and requirements for companies to undertake pediatric studies. more→
How the RACE for Children Act will get drugs to kids with cancer (The Cancer Letter, by Nancy Goodman)
Taken together, the RACE for Children Act and the Pediatric PRV program change the landscape of pediatric cancer research. more→
Don’t leave them waiting: How to bring new cancer drugs to kids (Morning Consult, by Elena Gerasimov)
The RACE Act is needed because most kids with cancer are treated with medicines from the time when my mom was young. more→
Nancy Goodman speaks at Summit 2016 Entrepreneurship at Cornell
Nancy Goodman, CEO, Kids v. Cancer from Eship@Cornell on Vimeo.
Too many PD-1 trials for adults, too few for children (The Cancer Letter, by Nancy Goodman)
Why are there so few trials for which children and young teens would qualify? Shouldn’t kids and teens also get a shot at exciting investigational drugs? more→
Letter to Commissioner Califf requesting the establishment of a Pediatric Cancer Cluster
A letter to the FDA Commissioner from the pediatric cancer community requesting the establishment of a Pediatric Cancer Cluster to further promote international scientific exchange and to harmonize global pediatric cancer drug development. more→
Saved Josh: The gears of a successful patient advocacy campaign (Case study, by Elena Gerasimov)
Read a detailed account of a case of a 7-year-old boy whose request to be treated with an experimental drug started the nationwide conversation about compassionate use. more→
Testimony of Nancy Goodman before the Committee on Homeland Security and Governmental Affairs
On February 25, 2016 Nancy Goodman testified on how to connect patients to new and potential life-saving treatments. more→
Letter to the Editor (The Washington Post, by Nancy Goodman)
Nancy Goodman advocates for pain medicines for seriously ill children. more→
Laws need to catch up to the science (The Cancer Letter, by Nancy Goodman)
Kids with cancer are the last, not the first, to get on trials of promising new drugs. more→
Kids with cancer need access to drug trials (CNBC)
We have reached a first tipping point in pediatric drug development. Where it was once financially unfeasible, businesses now have a good, bottom-line oriented reason to develop drugs for kids with cancer and the rare diseases. more→